Stay updated with breaking news from Project Angie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mind Medicine(NASDAQ:NASDAQ:MNMD) Q1 2022 Earnings Conference Call May16, 2022, 08:30AM ET Company Participants Rob Barrow - CEO Dan Karlin - Chief Medical Officer Miri Halperin Wernli -...
/PRNewswire/ -- MindMed (Nasdaq: MNMD), (NEO: MMED), (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its...
The initial trial would focus on dosage before expanding into psilocybin treatments for a variety of health conditions. “This is another important step for our commitment to the development of naturally sourced, evidence-based product formulations,” said Optimi chairman of the board JJ Wilson. The information package included the investigational product’s chemical constituents, genotype, and formulation as well as procedures and processes to produce a consistent dosage from psilocybe mushrooms. Optimi will retain 100 per cent ownership of the resulting all-natural psilocybin capsule and...
Certain Highlights for 2020 and Subsequent to the Year-End Include Closing the Platinum Vape and Acreage Florida Acquisitions Red White & Bloom (CSE:RWB) (OTCQX:RWBYF) anticipates filing its 2020 audited financial statements on or before May 31, 2021. As a result of this announcement, RWB provided certain 2020 and subsequent financial results. System-wide product sales for the company, which excludes RWB Michigan, RWB Florida and RWB Illinois, in the fourth quarter of 2020 was approximately CDN $26.5 million, an increase of 218% over the third quarter and the first full quarter post-closing ...
"Evidence dating back to the 1950s suggests that LSD and other psychedelics may have analgesic effects, but this treatment area remains largely untapped by…